A dose-escalating clinical trial with KH176

Phase 1

Completed

• Conditions: Mitochondrial disease; Genetic Diseases

• Registration Number: ISRCTN43372293
• Lead Sponsor: Khondrion

Brief Summary

2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/29037240

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2015-10-10
• Study Start: 2017-06-27
• Last Update Posted: 20 August 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

1. Healthy as assessed by medical history, physical examination, vital signs, clinical laboratory, ECG
2. Adult males

Exclusion Criteria

1. Allergies
2. Concomitant medication
3. Concomitant disease
4. Relevant surgery
5. Recent blood donation

Study & Design

• Study Type: Interventional
• Study Design: Not specified